Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 2027915

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 2027915

United States Sleep Apnea Devices Market Report by Products Types, Therapeutics, Diagnostics, End User, States and Company Analysis 2026-2034

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3490
PDF (5 User License + Excel)
USD 3990
PDF (Corporate License)
USD 4490

Add to Cart

United States Sleep Apnea Devices Market Size & Forecast 2026-2034

The United States Sleep Apnea Devices Market is estimated to grow from USD 2.16 billion in 2025 to USD 3.68 billion in 2034, at a CAGR of 6.11% from 2026 to 2034. The growth in the United States Sleep Apnea Devices Market is due to the rising incidence of sleep apnea, increased awareness of sleep disorders, and the development of sleep disorder detection and treatment devices such as CPAP and BiPAP machines. Moreover, the increase in the number of health facilities and the use of home care services are boosting the market.

United States Sleep Apnea Devices Market Outlooks

Sleep apnea devices are medical devices intended for the diagnosis and treatment of sleep apnea, which is a condition in which breathing stops and starts while an individual sleep. The devices include CPAP machines, BiPAP machines, oral devices, and sleep monitors. These devices ensure the smooth flow of air and the opening of airways to allow individuals to sleep uninterrupted. They help in the prevention of health risks resulting from sleep apnea. The use of sleep apnea devices in the United States has become increasingly popular. This has been driven by the rising awareness of sleep disorders and the effects they have on health.

The majority of the population suffers from sleep apnea. The condition has been noted in the majority of obese and physically inactive individuals. The recent advances in technology have seen the design of more comfortable devices. These advances have seen the popularity of the devices increase. The health infrastructure in the United States has been supportive of the use of sleep apnea devices. The recent focus on preventive health has seen the popularity of the devices increase.

Growth Drivers of the United States Sleep Apnea Devices Market

Rising Prevalence of Sleep Apnea and Lifestyle-Related Disorders

The New ResMed Study estimates that by the year 2050, OSA is expected to affect nearly 77 million adult Americans, which is an increase of nearly 35% relative to the year 2020, while at the same time OSA is expected to affect 46% of the adult population aged between 30 and 69 years. This is the first study of its kind aimed at estimating OSA prevalence in the US between the years 2020 and 2050. The rising prevalence of sleep apnea in the US is seen as a key factor driving the sleep apnea market. Factors like obesity, lack of exercise, an aging population, and rising stress levels are causing sleep apnea to affect an increased number of people in the US. A large number of the adult population remains undiagnosed. This is because, as the public is becoming more aware of the health hazards of untreated sleep apnea, such as heart problems, diabetes, and hypertension, they are seeking medical diagnosis and treatment. Furthermore, the increased focus on sleep health as part of a healthy lifestyle is another factor contributing to the demand for sleep apnea devices. This rising incidence of sleep apnea is expected to boost the sleep apnea devices market in the United States.

Technological Advancements and Product Innovation

Innovation in terms of technology is playing an important role in the growth of the sleep apnea devices market in the US. New-age sleep apnea devices, including CPAP and BiPAP machines, have become much lighter and easier to use. Technological innovations have made these devices much quieter and have made patients feel much more comfortable. New innovations have been introduced to make these devices much easier to use. For example, features have been introduced to allow patients to adjust the pressure according to their requirements. Similarly, innovations have been introduced to make these devices compatible with various smartphones. New-age sleep apnea devices have made it much easier for patients to diagnose their condition. Wearable devices have been introduced to help patients diagnose their condition while staying at their homes. Technological innovations have made sleep apnea devices much more comfortable to wear. This is one of the major factors that have been holding back the growth of the sleep apnea devices market. August 2025, Nyxoah, a medical technology company focused on the treatment of obstructive sleep apnea (OSA), has said the FDA has approved its Genio system for a subset of patients with moderate to severe OSA and an apnea-hyponea index (AHI) ranging from more than or equal to 15 up to and including 65.

Expansion of Home Healthcare and Favorable Reimbursement Policies

The rising trend of home healthcare is greatly contributing to the increased demand for sleep apnea devices in the US. This is because patients are preferring home diagnosis and treatment of sleep apnea due to their convenience, cost-effectiveness, and lack of need for hospitalization. Portable sleep diagnosis devices and simple-to-use CPAP machines are helping patients effectively manage sleep apnea at home. Moreover, favorable reimbursement policies for sleep apnea diagnosis and treatment are positively contributing to the demand for sleep apnea devices. Many sleep apnea diagnosis and treatment costs are covered by insurance providers, as well as Medicare. This is encouraging patients to opt for sleep apnea diagnosis and treatment. Healthcare providers are also encouraging home healthcare because of the reduced pressure on hospitals. This is expected to positively impact the sleep apnea devices market in the coming years because home healthcare is rising. April 2024, Fisher & Paykel Healthcare Corporation Limited announced the launch of the F&P Solo Nasal mask in the USA for the treatment of obstructive sleep apnea (OSA).

Challenges of the United States Sleep Apnea Devices Market

Low Patient Compliance and Device Discomfort

One of the key issues in the sleep apnea devices market is the lack of compliance among patients, especially those who use CPAP therapy. This is because patients find the therapy uncomfortable, which can be attributed to factors like the pressure of the masks, discomfort from the masks, and noise. This discomfort can cause patients to be less compliant or even stop using the therapy entirely, which can affect the success of the therapy. Psychological factors like anxiety and claustrophobia can also affect the success of the therapy. Although technology has improved sleep apnea therapy, ensuring compliance remains an issue. This is because ensuring compliance is important in ensuring the success of the therapy. Non-compliance does not only affect the success of the therapy but can also affect the success of the sleep apnea therapy device. This is because ensuring compliance is important in ensuring the success of the therapy.

High Cost of Devices and Limited Awareness in the Undiagnosed Population

The high cost of advanced sleep apnea devices is one factor that can be seen as a deterrent in the market. Although the devices are covered under insurance policies, the out-of-pocket expenses can be substantial. As such, it can be seen as a deterrent that can affect the overall adoption of the devices by the population. Furthermore, the undiagnosed population suffering from sleep apnea is quite large. The lack of awareness or the unwillingness of the population to undergo sleep studies is one reason why the market potential is not fully utilized. The majority of the population is not aware of the symptoms of sleep apnea, such as snoring or fatigue. As such, it can be seen as one factor that can be overcome by increasing awareness about the devices.

United States Sleep Apnea Therapeutic Devices Market

The United States sleep apnea therapeutic devices market is witnessing steady growth due to the prevalence of sleep disorders and the consequent requirement for effective treatment devices. Therapeutic devices such as CPAP, Bi-PAP, and ASV devices are commonly used to treat sleep apnea. These devices provide a constant flow of air, thus enhancing the quality of sleep and reducing the associated health risks. Awareness about the consequences of sleep disorders, such as cardiovascular diseases and fatigue, is also driving the demand for therapeutic devices. These devices have also become more compact and user-friendly owing to technological advancements. Home-based care and remote monitoring devices are also gaining traction in the sleep apnea therapeutic devices market in the United States. The healthcare infrastructure in the United States is robust, and the reimbursement policies also support the growth of the sleep apnea therapeutic devices market. Hence, therapeutic devices play a significant role in the management of sleep apnea.

United States CPAP Sleep Apnea Therapeutic Devices Market

The CPAP (Continuous Positive Airway Pressure) segment is dominating the sleep apnea therapeutic devices market in the United States. This is due to the effectiveness and popularity of this device. CPAP devices are considered the gold standard for treating obstructive sleep apnea. These devices provide a constant flow of air to keep the airway open. This increases the demand for these devices due to the growing rate of sleep apnea diagnosis and high recommendations from clinicians. New features have been introduced to these devices, including auto-adjusting pressure, humidifiers, and better mask designs. This has made the device more acceptable by patients. Another feature is the ability to connect with apps and cloud-based services, which enables healthcare professionals to monitor patient usage. There are various product offerings and distribution channels that have contributed to the demand for this device. Despite the problem of patient compliance, this device is still the most popular and accepted solution to treating sleep apnea.

United States Sleep Apnea Polysomnography Devices Market

Polysomnography devices have a vital role to play in the diagnosis of sleep apnea and other sleep disorders in the United States. These polysomnography devices are used in sleep laboratories and hospitals for conducting sleep studies. These studies involve the measurement of brain activity, oxygen levels, heart rate, and breathing patterns. There is increasing awareness of sleep disorders and their need for proper diagnosis. This has resulted in increased demand for polysomnography devices. Advances in technology have enhanced the efficiency and accuracy of polysomnography devices. This has resulted in more accurate sleep studies. There is also a growing demand for polysomnography devices due to the increase in sleep clinics and diagnostic centers. Although traditional sleep studies are considered the gold standard for polysomnography, there is a growing trend towards portable polysomnography solutions. With early diagnosis becoming a prime focus, there is a growing demand for advanced polysomnography devices.

United States Sleep Apnea Oximeter Devices Market

The sleep apnea oximeter devices market is growing in the US due to the increasing demand for simple and non-invasive monitoring devices. Pulse oximeters are commonly used to measure the blood oxygen levels while an individual is sleeping. This is helpful in the preliminary detection and monitoring of sleep apnea. Pulse oximeters are easily employed in both home and clinical settings due to their affordability and simplicity. The growing trend of home healthcare and remote patient monitoring is greatly contributing to the demand for oximeter devices. Technological developments, including wearable and wireless oximeters, are making these devices extremely convenient and accurate. Moreover, with the integration of digital health platforms, users and healthcare professionals can easily monitor their sleep patterns and blood oxygen levels. Oximeter devices are becoming an essential tool to ensure the health and well-being of an individual while sleeping.

United States Sleep Apnea Devices Clinics & Hospitals Market

The clinics and hospitals are important participants in the sleep apnea devices market in the United States. They offer comprehensive services in the diagnosis and treatment of sleep apnea. These institutions are well-equipped with the latest technology, including polysomnography machines, which helps in the accurate diagnosis of sleep apnea. Moreover, the availability of well-trained medical experts is beneficial in ensuring better health outcomes. Furthermore, increased investments in the healthcare sector are expected to boost the sleep apnea devices market in the coming years. In addition, insurance policies support the diagnosis and treatment of sleep apnea in clinics, which is beneficial in raising awareness about the condition. This motivates patients to undergo diagnosis and treatment from qualified practitioners. With the growing awareness about sleep apnea, clinics and hospitals are important participants in the sleep apnea diagnosis and treatment devices market in the United States.

California Sleep Apnea Devices Market

The California sleep apnea devices market is a large market in the US, considering the high population and the high standard of healthcare infrastructure. Additionally, the state has a high population suffering from sleep disorders, especially due to lifestyle factors such as obesity, stress, and urbanization. Furthermore, the high standard of healthcare infrastructure in the state allows for the early diagnosis and treatment of sleep disorders. Additionally, the state's high standard of technology has led to the adoption of advanced sleep apnea devices, such as smart CPAP machines and wearable devices. The state has many medical device manufacturers and technology companies, which also contribute to the growth of the sleep apnea devices market in the state. Increased awareness about sleep health and the importance of preventive healthcare measures also contribute to the growth of the sleep apnea devices market in the state. Home healthcare and telemedicine services also contribute to the growth of the sleep apnea devices market in the state.

Florida Sleep Apnea Devices Market

The market for sleep apnea devices in Florida is greatly impacted by the state's large aging population, which has a high risk of developing sleep apnea. This has led to an increased need for diagnosis and treatment of the condition, thus propelling the market for sleep apnea devices in the state. Other lifestyle-related diseases, including obesity and cardiovascular diseases, have contributed to the increased prevalence of sleep apnea in the state. This has led to an increased need for diagnosis and treatment of the condition, thus propelling the market for sleep apnea devices in the state. In addition, the state has a well-developed healthcare infrastructure, thus facilitating diagnosis and treatment of the condition. Furthermore, the state has a well-developed home healthcare market, thus providing patients with the option of managing the condition at home. Therefore, it is anticipated that the sleep apnea devices market in the state will continue growing in line with the increasing aging population.

Georgia Sleep Apnea Devices Market

The Georgia sleep apnea devices market is growing steadily, with an increased awareness of sleep disorders and access to healthcare. The rise in obesity-related diseases is contributing to an increased incidence of sleep apnea. Healthcare professionals are raising awareness about sleep apnea, urging more and more patients to seek treatment for the condition. The expansion of hospitals, clinics, and diagnostic centers is providing better access to sleep apnea devices. The increased use of home care solutions is also providing better access to sleep apnea devices. Technological advancements in sleep apnea devices, such as the availability of user-friendly devices, are further adding to the growth of the sleep apnea devices market. Insurance and health programs from employers may be contributing to the growth of the sleep apnea devices market. The Georgia sleep apnea devices market is expected to grow steadily.

Washington Sleep Apnea Devices Market

The market for sleep apnea devices in the state of Washington is growing steadily and is fueled by high healthcare awareness and the adoption of advanced technologies. This is because the population is becoming increasingly health-conscious and is seeking to embrace health and wellness. This is creating a high demand for sleep apnea diagnosis and treatment. The presence of major technology players and the high level of innovation in the healthcare sector is encouraging the use of connected sleep apnea devices. This is because telemedicine and remote health monitoring solutions are already widespread, and patients are able to effectively manage their condition. Moreover, the healthcare system is well-equipped with modern facilities, including hospitals and sleep centers. This is encouraging the diagnosis and treatment of sleep apnea. There is high awareness about the correlation between sleep apnea and chronic health issues, including heart problems. This is likely to propel the growth of the sleep apnea devices market in the state of Washington.

United States Sleep Apnea Devices Market Segments

Types - Market breakup from 2 viewpoints:

1. Therapeutic Devices

2. Diagnostic Devices

Therapeutic Devices

1. CPAP Sleep Apnea Therapeutic Devices

2. Auto CPAP Sleep Apnea Therapeutic Devices

3. BiPAP Sleep Apnea Therapeutic Devices

4. Adaptive Servo-Ventilation (ASV)

Diagnostic Devices

1. Polysomnography Devices (PSG)

2. Oximeter

3. Actigraphy Monitoring Device

4. Respiratory Polygraph

5. Sleep Apnea Screening Device

End User

1. Sleep Laboratories, Clinics & Hospitals

2. Home Care Settings/Individuals

States

1. California

2. Texas

3. New York

4. Florida

5. Illinois

6. Pennsylvania

7. Ohio

8. Georgia

9. New Jersey

10. Washington

11. North Carolina

12. Massachusetts

13. Virginia

14. Michigan

15. Maryland

16. Colorado

17. Tennessee

18. Indiana

19. Arizona

20. Minnesota

21. Wisconsin

22. Missouri

23. Connecticut

24. South Carolina

25. Oregon

26. Louisiana

27. Alabama

28. Kentucky

29. Rest of United States

All companies have been covered with 5 Viewpoints

1. Overviews

2. Key Person

3. Recent Developments

4. SWOT Analysis

5. Revenue Analysis

Key Players Analysis

1. Carefusion Corp. (Part of Becton, Disckinson & Company)

2. Somnomed

3. ResMed Inc.

4. Koninklijke Philips N.V.

5. Compumedics

6. Natus Medical Incorporated

7. Teleflex Incorporated

8. Fisher &Paykel Healthcare

Table of Contents

1. Introduction

2. Research & Methodology

  • 2.1 Data Source
    • 2.1.1 Primary Sources
    • 2.1.2 Secondary Sources
  • 2.2 Research Approach
    • 2.2.1 Top-Down Approach
    • 2.2.2 Bottom-Up Approach
  • 2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. United States Sleep Apnea Devices Market

  • 5.1 Market Share Analysis
  • 5.2 By Products Types
  • 5.3 By Therapeutics
  • 5.4 By Diagnostics
  • 5.5 By End User
  • 5.6 By States

6. Product Types

  • 6.1 Therapeutic Devices
    • 6.1.1 Historical Market
    • 6.1.2 Market Forecast
  • 6.2 CPAP Sleep Apnea Therapeutic Devices
    • 6.2.1 Historical Market
    • 6.2.2 Market Forecast
  • 6.3 Auto CPAP Sleep Apnea Therapeutic Devices
    • 6.3.1 Historical Market
    • 6.3.2 Market Forecast
  • 6.4 BiPAP Sleep Apnea Therapeutic Devices
    • 6.4.1 Historical Market
    • 6.4.2 Market Forecast
  • 6.5 Adaptive Servo-Ventilation (ASV)
    • 6.5.1 Historical Market
    • 6.5.2 Market Forecast
  • 6.6 Diagnostic Devices
    • 6.6.1 Historical Market
    • 6.6.2 Market Forecast
  • 6.7 Polysomnography Devices (PSG)
    • 6.7.1 Historical Market
    • 6.7.2 Market Forecast
  • 6.8 Oximeter
    • 6.8.1 Historical Market
    • 6.8.2 Market Forecast
  • 6.9 Actigraphy Monitoring Device
    • 6.9.1 Historical Market
    • 6.9.2 Market Forecast
  • 6.10 Respiratory Polygraph
    • 6.10.1 Historical Market
    • 6.10.2 Market Forecast
  • 6.11 Sleep Apnea Screening Device
    • 6.11.1 Historical Market
    • 6.11.2 Market Forecast

7. End User

  • 7.1 Sleep Laboratories, Clinics & Hospitals
    • 7.1.1 Historical Market
    • 7.1.2 Market Forecast
  • 7.2 Home Care Settings/Individuals
    • 7.2.1 Historical Market
    • 7.2.2 Market Forecast

8. States

  • 8.1 California
    • 8.1.1 Historical Market
    • 8.1.2 Market Forecast
  • 8.2 Texas
    • 8.2.1 Historical Market
    • 8.2.2 Market Forecast
  • 8.3 New York
    • 8.3.1 Historical Market
    • 8.3.2 Market Forecast
  • 8.4 Florida
    • 8.4.1 Historical Market
    • 8.4.2 Market Forecast
  • 8.5 Illinois
    • 8.5.1 Historical Market
    • 8.5.2 Market Forecast
  • 8.6 Pennsylvania
    • 8.6.1 Historical Market
    • 8.6.2 Market Forecast
  • 8.7 Ohio
    • 8.7.1 Historical Market
    • 8.7.2 Market Forecast
  • 8.8 Georgia
    • 8.8.1 Historical Market
    • 8.8.2 Market Forecast
  • 8.9 New Jersey
    • 8.9.1 Historical Market
    • 8.9.2 Market Forecast
  • 8.10 Washington
    • 8.10.1 Historical Market
    • 8.10.2 Market Forecast
  • 8.11 North Carolina
    • 8.11.1 Historical Market
    • 8.11.2 Market Forecast
  • 8.12 Massachusetts
    • 8.12.1 Historical Market
    • 8.12.2 Market Forecast
  • 8.13 Virginia
    • 8.13.1 Historical Market
    • 8.13.2 Market Forecast
  • 8.14 Michigan
    • 8.14.1 Historical Market
    • 8.14.2 Market Forecast
  • 8.15 Maryland
    • 8.15.1 Historical Market
    • 8.15.2 Market Forecast
  • 8.16 Colorado
    • 8.16.1 Historical Market
    • 8.16.2 Market Forecast
  • 8.17 Tennessee
    • 8.17.1 Historical Market
    • 8.17.2 Market Forecast
  • 8.18 Indiana
    • 8.18.1 Historical Market
    • 8.18.2 Market Forecast
  • 8.19 Arizona
    • 8.19.1 Historical Market
    • 8.19.2 Market Forecast
  • 8.20 Minnesota
    • 8.20.1 Historical Market
    • 8.20.2 Market Forecast
  • 8.21 Wisconsin
    • 8.21.1 Historical Market
    • 8.21.2 Market Forecast
  • 8.22 Missouri
    • 8.22.1 Historical Market
    • 8.22.2 Market Forecast
  • 8.23 Connecticut
    • 8.23.1 Historical Market
    • 8.23.2 Market Forecast
  • 8.24 South Carolina
    • 8.24.1 Historical Market
    • 8.24.2 Market Forecast
  • 8.25 Oregon
    • 8.25.1 Historical Market
    • 8.25.2 Market Forecast
  • 8.26 Louisiana
    • 8.26.1 Historical Market
    • 8.26.2 Market Forecast
  • 8.27 Alabama
    • 8.27.1 Historical Market
    • 8.27.2 Market Forecast
  • 8.28 Kentucky
    • 8.28.1 Historical Market
    • 8.28.2 Market Forecast
  • 8.29 Rest of United States
    • 8.29.1 Historical Market
    • 8.29.2 Market Forecast

9. Porter's Five Analysis

  • 9.1 Bargaining Power of Buyers
  • 9.2 Bargaining Power of Suppliers
  • 9.3 Degree of Rivalry
  • 9.4 Threat of New Entrants
  • 9.5 Threat of Substitutes

10. SWOT Analysis

  • 10.1 Strength
  • 10.2 Weakness
  • 10.3 Opportunity
  • 10.4 Threat

11. Key Players Analysis

  • 11.1 Carefusion Corp. (Part of Becton, Disckinson & Company)
    • 11.1.1 Overviews
    • 11.1.2 Key Person
    • 11.1.3 Recent Developments
    • 11.1.4 SWOT Analysis
    • 11.1.5 Revenue Analysis
  • 11.2 Somnomed
    • 11.2.1 Overviews
    • 11.2.2 Key Person
    • 11.2.3 Recent Developments
    • 11.2.4 SWOT Analysis
    • 11.2.5 Revenue Analysis
  • 11.3 ResMed Inc.
    • 11.3.1 Overviews
    • 11.3.2 Key Person
    • 11.3.3 Recent Developments
    • 11.3.4 SWOT Analysis
    • 11.3.5 Revenue Analysis
  • 11.4 Koninklijke Philips N.V.
    • 11.4.1 Overviews
    • 11.4.2 Key Person
    • 11.4.3 Recent Developments
    • 11.4.4 SWOT Analysis
    • 11.4.5 Revenue Analysis
  • 11.5 Compumedics
    • 11.5.1 Overviews
    • 11.5.2 Key Person
    • 11.5.3 Recent Developments
    • 11.5.4 SWOT Analysis
    • 11.5.5 Revenue Analysis
  • 11.6 Natus Medical Incorporated
    • 11.6.1 Overviews
    • 11.6.2 Key Person
    • 11.6.3 Recent Developments
    • 11.6.4 SWOT Analysis
    • 11.6.5 Revenue Analysis
  • 11.7 Teleflex Incorporated
    • 11.7.1 Overviews
    • 11.7.2 Key Person
    • 11.7.3 Recent Developments
    • 11.7.4 SWOT Analysis
    • 11.7.5 Revenue Analysis
  • 11.8 Fisher &Paykel Healthcare
    • 11.8.1 Overviews
    • 11.8.2 Key Person
    • 11.8.3 Recent Developments
    • 11.8.4 SWOT Analysis
    • 11.8.5 Revenue Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!